Article

Can Zinc Correction in SARS-CoV-2 Patients Improve Treatment Outcomes?

2020-04-07

Abstract excerpt

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic for which there is no established treatment available yet, has caused more than 68,000 deaths so far. Following the SARS-CoV outbreak in 2003, an Italian group described a hypothesis about the efficacy of two old drugs: Chloroquine (CQ) and Hydroxychloroquine (HCQ), against SARS-CoV and its future emergents. Later, this hypothesis wa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 229b93a2-a57a-52f1-9f87-7f837d48f6be
DOI: 10.20944/preprints202004.0094.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Can Zinc Correction in SARS-CoV-2 Patients Improve Treatment Outcomes?DOI 10.20944/preprints202004.0094.v1Read

Zinc <sup>2+</sup> ion inhibits SARS-CoV-2 main protease and viral replication <i>in vitro</i>Semantic proximity Read

Low Zinc Levels at Clinical Admission Associates with Poor Outcomes in COVID-19Semantic proximity Read

Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectorsSemantic proximity Read

Hydroxychloroquine inhibits trained immunity – implications for COVID-19Semantic proximity Read

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitroSemantic proximity Read

Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variantsSemantic proximity Read

In vitro determination of inhibitory effects by humic substances complexing Zn and Se on SARS-CoV-2 virus replicationSemantic proximity Read

Low zinc levels at clinical admission associates with poor outcomes in COVID-19Semantic proximity Read